As 2018 came to a close, Life Science Leader interviewed industry leaders about what to expect in the coming years in biopharma.
Our CEO and founder, Nazli Azimil, Pharm.D., Ph.D., said, “Sometimes a fresh look from outsiders might be just what our industry needs. A true biopsy report of our healthcare system or any progressive solution that this initiative may provide could be valuable information for healthcare stakeholders and political leaders.”
Click here to read the full article (subscription required).
